{
  "id": 9794778,
  "title": "How the treatment of interleukin-6-driven diseases can be refined",
  "url": "https://urgent.news/2026/09/25/how-the-treatment-of-interleukin-6-driven-diseases-can-be-refined",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-25T16:20:12.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-09-treatment-interleukin-driven-diseases-refined.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Interleukin-6 (IL-6) is a contradictory molecule in immunology. It helps the liver regenerate after injury and protects against infections, yet it also drives chronic inflammation in rheumatic diseases, inflammatory bowel disease and atherosclerosis. Current drugs block IL-6 across the board: They protect against inflammation but also switch off its beneficial functions.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}